Read in Spanish
Mexico City. On June 8th and 9th, the second edition of the “Symposium of Medicinal Cannabis” was held in Mexico City, whose main objective was to present the first permits for the distribution of medicinal products.
The regulation in Mexico for the distribution of medicinal cannabis allows exclusively the commercialization of cannabidiol (CBD) products, one of the 110+ cannabinoids. The harvest has been granted to very few places, since right now the most viable is the import with the brands authorized by the Federal Commission for the Protection against Health Risks (Cofepris).
The first to have permission from Cofepris has been CalyFX as corroborated by MCN. Its products are CBD cartridges for various symptoms.
CIBIDIUM, another authorized distributor, produces cannabidiol (CBD) and cannabigerol (CBG) oil, the first official brand to import this cannabinoid to Mexico.
CBG is a non-psychoactive cannabinoid considered a precursor of delta 9 tetrahydrocannabinol (THC) and cannabidiol (CBD). Although their percentages in cannabis are much lower, researchers have discovered great benefits. Among them: anti-inflammatory, antibacterial and side effects of cancer.
Although these were the only two brands that MCN Mexico was able to corroborate that they already had their distribution permit, various activism societies such as EXPOWEED and CANAPEUTAS were also presented.
Both as social groups that seek to inform not only the society and help the destigmatization of cannabis, but also advise doctors and train journalists, politicians, lawyers, patients and doctors on how they can from their profession help the same patients to protect the moral integrity of the affected person.
The Symposium also featured several doctors such as Dr. Juan Carlos Restrepo whose focus was on cancer and how the various properties of plants work to treat different diseases in different ways.
He also talked about how doctors can advise their patients, recalls that we should be on the lookout for certified brands and that they rely on this.
Since 2017, Cofepris issued a statement in which it reported that legislation processes were being started so that people who need to import cannabis for medical purposes can do so without entering into a lack administrative
Earlier this year, Cofepris announced that it had received 350 applications for permits but only a few cases could be resolved and through amparo, however, from April, the Senate published regulations for the importation of products based on Cannabis for medicinal purposes.
The medicinal cannabis initiative in Mexico has the support of the Senate and the Supreme Court of Justice.
Photos: Eduardo Blass / Cannal MX
Follow us on Instagram